Adjuvant effect of zinc oxide on Th2 but not Th1 immune responses in mice

Immunopharmacology and Immunotoxicology

Volumn 32, Issue 1, 2010, Pages 56-62

  Matsumura, Misa ^a,b   Nagata, Masafumi ^b   Nakamura, Kazuichi ^b   Kawai, Motoyuki ^b   Baba, Takahiko ^b   Yamaki, Kouya ^a   Yoshino, Shin ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Adjuvant; Antibody; Cytokine; Th1; Th2; Zinc oxide

Indexed keywords

ALUMINUM HYDROXIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; ZINC OXIDE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; CYTOKINES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED DBA; OVALBUMIN; TH1 CELLS; TH2 CELLS; ZINC OXIDE;

MUS;

EID: 77249092583     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970903124627     Document Type: Article

References (36)

1. Scientific Committee on Cosmetic Products and Non-Food Products (SCCNFP) Evaluation and Opinion on: Zinc Oxide. 24th plenary meeting, Brussels. 2003.
2. Gulson B, Wong H, McCall M, Casey P, Trotter J, McCulloch M, et al. Dermal absorption of ZnO nanoparticles in sunscreen using the stable isotope approach. Toxicol Letts 2008;180:S222.
3. Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P. Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol 2007;20: 148-154.
4. Guo D, Wu C, Jiang H, Li Q, Wang X, Chen B. Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation. Photochem Photobiol B.2008;93:119-126.
5. Reddy KM, Feris K, Bell J, Wingett DG, Hanley C, Punnoose A. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl Phys Lett 2007;90:1-3.
6. Mossman TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1987;7:145-173.
7. Yoshino S, Yamaki K, Yanagisawa R, Takano H, Hayashi H, Mori Y. Effects of bisphenol A on antigen-specific antibody production, proliferative responses of lymphoid cells, and Th1 and TH2 immune responses in mice. Br J Pharmacol 2003;138:1271-1276.
8. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8: 345-350.
9. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007;13:139-145.
10. Yamaki K, Uchida H, Harada Y, Yanagisawa R, Takano H, Hayashi H, et al. Effect of the nonsteroidal anti-inflammatory drug indomethacin on Th1 and Th2 immune responses in mice. J Pharm Sci 2003;92:1723-1729.
11. Kuschner WG., D'Alessandro A, Hambleton J, Blanc PD. Tumor necrosis factor-a and interleukin-8 release from U937 human mononuclear cells exposed to zinc oxide in vitro: Mechanistic implications for metal fume fever. J Occup Environ Med 1998;40:454-459.
12. Gojova A, Guo B, Kota S, Rutledge JC, Kennedy IM, Barakat AI. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticle: effect of particle composition. Environ Health Perspect 2007;115:403-409.
13. Burstein HJ, Abbas AK. In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med 1993;177:457-463.
14. Mosmann TR, Moore KW. The role of IL-10 in cross-regulation of Th1 and Th2 responses. Immunol Today 1991;12: A49-A53.
15. Brewer JM, Conacher M, Satoskar A, Bluethmann H, Alexander J. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur J Immunol 1996;26:2062-2066.
16. Grun JL, Maurer PH. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. Cell Immunol 1989;121:134-145.
17. Eisenbarth SC, Colegio OR, O'Connor Jr W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasole in the immunostimulatory properties of aluminium adjuvants. Nature 2008;453:1122-1127.
18. Yang Z, Xie C. Zn2+ release from zinc and zinc oxide particles in simulated uterine solution. Colloids Surfaces 2006;47:140-145.
19. Winchurch RA, Togo J, Adler WH. Supplemental zinc (Zn2+) restores antibody formation in cultures of aged spleen cells. II. Effects on mediator production. Eur J Immunol 1987;17:127-132.
20. Brazão V, Caetano LC, Filipin Mdel. V, Santello FH, Toldo MP, do Prado JC. Trypanosoma cruzi: The effects of zinc supplementation in the immune response during the course of experimental disease. Exp Parasitol 2009;121:105-109.
21. Ozturk G, Erbas D, Imir T, Bor NM. Decreased natural killer (NK) cell activity in zinc-deficient rats. Gen Pharmacol 1994;25:1499-1503.
22. Chen CH, Huang YL, Yen CM. The influence of zinc in mice on infection with angiostrongylus cantonensis. Parasitol Res 2004;94:74-81.
23. Fong LY, Jiang Y, Farber JL. Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53- deficient mice. Carcinogenesis 2006;27:1489-1496.
24. Shi HN, Scott ME, Stevenson MM, Koski KG. Zinc deficiency impairs T cell function in mice with primary infection of Heligmosomoides polygyrus (Nematode). Parasite Immunol 1994;16:339-350.
25. Scott ME, Koski KG.. Zinc deficiency impairs immune responses against parasitic nematode infections at intestinal and systemic sites. J Nutr 2000;130:1412S-1420S.
26. Martinez G.J, Nurieva RI, Yang XO, Dong C. Regulation and function of proinflammatory Th17 cells. Ann N.Y Acad Sci 2008;1143:188-211.
27. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-238.
28. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM. Stockinger, B. TGF in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-produing T cells. Immunity 2006;24:179-189.
29. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-α induces development of the T(H)17 linage. Nature 2006;441:231-234.
30. Kuschner WG., D'Allesandro A, Wong H, Blanc PD. Early pulmonary cytokine responses to zinc oxide fume inhalation. Environ Res 1997;75:7-11.
31. Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, Sato E, et al. Zinc is a novel intracellular second messenger. J Cell Biol 2007;177:637-645.
32. Granum B, Gaarder P.I, Groeng E. Leikvold, R Namork E. Lovik M. Fine particles of widely different composition have an adjuvant effect on the production of allergen-specific antibodies. Toxicol Lett 2001;118:171-181.
33. Takafuji S, Suzuki S, Koizumi K, Tadokoro K, Ohashi H, Muranaka M, et al. Enhancing effect of suspended particulate matter on the IgE antibody production in mice. Int Arch Allergy Appl Immunol 1989;90:1-7.
34. Martínez-Rodríguez S, Encinar JA, Hurtado-Gómez E, Prieto J, Clemente-Jiménez JM, Las Heras-Vázquez FJ, et al. Metaltriggered changes in the stability and secondary structure of a tetrameric dihydropyrimidinase: a biophysical characterization. Biophys Chem 2009;139:42-52.
35. Goux WJ, Venkatasubramanian PN. Metal ion binding properties of hen ovalbumin and S-ovalbumin: characterization of the metal ion binding site by 31P NMR and water proton relaxation rate enhancements. Biochemistry 1986; 25:84-94.
36. Lucarelli M, Gatti A.M, Savarino G, Quattroni P, Martinelli L, Monari E, et al. Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur Cytokine Network 2004;15:339-346.